Invitrogen™ Kit ELISA of rat ligand FAS

Ref.: BL-RE-091709Manufacturer ref.: ERFASLGX10 10 x 96 tests
€4,815.00 excl. VAT

CD178 is a type II membrane protein with the N-terminal end in the cytoplasm and the C-terminal region extending into the extracellular space. Its receptor, FasR, is a type I membrane protein of cellular surface...

Accession number
P36940
Dose range
82.30 to 60.000 pg/ml
Sensitivity of the dosage
90 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

CD178 is a type II membrane protein with the N-terminal end in the cytoplasm and the C-terminal region extending into the extracellular space. Its receptor, FasR, is a type I membrane protein of cellular surface...

CD178 is a type II membrane protein with the N-terminal end in the cytoplasm and the C-terminal region extending into the extracellular space. Its receptor, FasR, is a type I cell surface membrane protein and a member of the NGF TNFet receptor family. As a member of the TNF-cytokine family, CD178 induces apoptosis during interaction with FasR. CD178 may exist as a bound (45 kD) or soluble (26 kD) membrane. The soluble protein can be released from the cells during cleavage by metalloproteinases. The binding of CD178 to Fas leads to receptor oligomerization and triggers death of apoptotic cells through the interaction of other proteins. CD178 is expressed predominantly in activated T-cells and natural killer cells, and also in tissues of immunological sites such as testicles and eyes. CD178 expression is also reported in a variety of tissues such as thymus, liver, lovary, lung, heart and kidney. It is assumed that CD178 induction of apoptosis is predominantly involved in antiviral immune responses. CD178 is a cell surface molecule belonging to the tumour necrosis factor family, and binds to its Fas receptor, thus inducing l-apoptosis. Different cells express Fas, where CD178 is expressed mainly on activated T cells. FAS and CD178 are involved in the downward regulation of immune reactions as well as T-cell cytotoxicity. CD178 concentration was also shown to be associated with atherosclerosis and inflammatory disease in patients with hypertension

Sensitivity

Sensitivity of the dosage: 90 pg/ml.

Measurement range

Dose range: 82.30 to 60.000 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: Ligand Fas (CD178).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17728243
Specifications
Accession numberP36940
Dose range82.30 to 60.000 pg/ml
Sensitivity of the dosage90 pg/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)25385
Gene symbol(s)Faslig
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusRUO
TargetLigand Fas (CD178)
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 50 μl-Serum, 50 μl-Surnatant, 100 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.ERFASLGX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.